Intervention not reported
Mortality All‐cause death · Pregnant women (parity 2+)
It is very uncertain whether the intervention changes mortality All‐cause death (very low certainty).
1 finding from 1 review
Intervention not reported
Mortality All‐cause death · Pregnant women (all parities)
The intervention showed no clear difference in mortality All‐cause death (low certainty).
1 finding from 1 review
Intervention not reported
Mortality All‐cause death · Pregnant women (parity 0‐1)
It is very uncertain whether the intervention changes mortality All‐cause death (very low certainty).
1 finding from 1 review
Neonatal mortality · neonates born from 35 weeks of gestation who have underdone gastrointestinal surgery
1 finding from 1 review
Mortality before hospital discharge · neonates born from 35 weeks of gestation who have underdone gastrointestinal surgery
1 finding from 1 review
All‐cause short‐term mortality: 1 month · adults with cardiogenic shock or low cardiac output syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality during hospital stay · neonates with sepsis
Pentoxifylline with antibiotics (any dose or duration) may leads to lower all‐cause mortality during hospital stay compared with placebo or no intervention (low certainty).
1 finding from 1 review
Death at hospital discharge · individuals with moderate to severe disease
1 finding from 1 review
All‐cause mortality assessed up to day 28 · individuals with moderate or severe COVID‐19
1 finding from 1 review
All‐cause mortality (30 days post‐surgery) · people undergoing definitive fixation of hip, pelvic and long bone fractures
Intravenous tranexamic acid showed no clear difference in all‐cause mortality (30 days post‐surgery) compared with placebo (low certainty).
1 finding from 1 review
All‐cause mortality (30 days post‐surgery) · people undergoing definitive fixation of hip, pelvic and long bone fractures
It is very uncertain whether topical tranexamic acid changes all‐cause mortality (30 days post‐surgery) compared with placebo (very low certainty).
1 finding from 1 review
Death during study period · people with acute ischemic stroke
Citicoline showed no clear difference in all‐cause mortality (at any time of trial) compared with placebo or standard treatment (low certainty).
1 finding from 1 review
Early all‐cause mortality (within 30 days) · adults undergoing non‐cardiac surgery under general anaesthesia (to include: low‐risk, medium‐risk, and high‐risk surgeries)
Perioperative beta‐blockers showed no clear difference in early all‐cause mortality (within 30 days) compared with placebo or standard care (low certainty).
1 finding from 1 review
All‐cause mortality at up to day 28 ‐ total · individuals with moderate to severe disease
Summary of findings table ‐ Convalescent plasma showed no clear difference in all‐cause mortality at up to day 28 ‐ total compared with placebo or standard care alone (high certainty).
1 finding from 1 review
Maternal death · HIV‐positive pregnant women co‐infected with hepatitis B virus
1 finding from 1 review
All‐cause mortality at 'less than 3 months' · patients with suspected or diagnosed myocardial infarction
Beta‐blockers showed no clear difference in all‐cause mortality at 'less than 3 months' compared with placebo or no intervention (high certainty).
1 finding from 1 review
All‐cause mortality or liver transplantation · patients with primary biliary cirrhosis.
It is very uncertain whether ursodeoxycholic acid changes all‐cause mortality or liver transplantation compared with placebo or no intervention (very low certainty).
1 finding from 1 review
All‐cause mortality ‐ adults and adolescents · patients with chronic asthma
Regular salmeterol showed no clear difference in all‐cause mortality ‐ adults and adolescents compared with placebo (moderate certainty).
1 finding from 1 review
Mortality within the longest · adults (aged 18 years or older), mechanically ventilated participants with ARDS as defined by the Berlin definition of ARDS or, for older…
Omega‐3 fatty acids and antioxidants showed no clear difference in all‐cause mortality (longest period reported) compared with placebo or standard nutrition (low certainty).
1 finding from 1 review
All‐cause mortality in 30 days post operation · patients (15 years of age and older) undergoing non‐cardiac surgery under any type of anaesthesia
It is very uncertain whether nitroglycerin changes all‐cause mortality in 30 days post operation compared with placebo (very low certainty).
1 finding from 1 review